Filing Details
- Accession Number:
- 0001437749-25-022547
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-07-10 20:49:15
- Reporting Period:
- 2025-07-08
- Filing Date:
- 2025-07-10
- Accepted Time:
- 2025-07-10 20:49:15
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1401667 | Puma Biotechnology Inc. | PBYI | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1358285 | H Alan Auerbach | C/O Puma Biotechnology, Inc. 10880 Wilshire Blvd., Suite 2150 Los Angeles CA 90024 | President And Ceo | Yes | Yes | Yes | No |
Transaction Summary
Sold: | 47,172 shares | Avg. Price: $3.53 | Total Value: $166,701.84 |
Number of Shares After Transactions: | 7,180,901 shares |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2025-07-08 | 25,592 | $3.53 | 7,202,481 | No | 4 | S | Direct | |
Common Stock | Disposition | 2025-07-09 | 21,580 | $3.54 | 7,180,901 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- Adoption date of referenced 10b5-1(c) plan is: 12-17-2020